These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 977186)

  • 1. Immunosuppression in Burkitt's lymphoma. II. Peripheral blood lymphocyte populations related to clinical status.
    Magrath IT; Simon RM
    Int J Cancer; 1976 Oct; 18(4):399-408. PubMed ID: 977186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E and EAC rosette-forming cells in healthy donors and cancer patients.
    Middelkoop OP; Veldhuizen RW; Scheper RJ
    Int Arch Allergy Appl Immunol; 1976; 52(1-4):412-6. PubMed ID: 1087922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro immunological studies on East African cancer patients. II. Increased sensitivity of blood lymphocytes from untreated Burkitt lymphoma patients to inhibition of spontaneous rosette formation.
    Gross RL; Levin AG; Steel CM; Singh S; Brubaker G; Peers FG
    Int J Cancer; 1975 Jan; 15(1):132-8. PubMed ID: 1079202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional activities of rosette separated human peripheral blood leukocytes.
    Dean JH; Silva JS; McCOY JL; Leonard CM; Cannon GB; Herberman RB
    J Immunol; 1975 Nov; 115(5):1449-55. PubMed ID: 126261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The follow-up study of skin reactivity to recall antigens and E- and EAC-RFC profiles in blood in asbestos workers.
    Lange A; Skibiński G; Garncarek D
    Immunobiology; 1980 Apr; 157(1):1-11. PubMed ID: 6970716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte populations in peripheral blood in hyperthyroid and euthyroid subjects.
    Lundell G; Wasserman J; Granberg PO; Blomgren H
    Clin Exp Immunol; 1976 Jan; 23(1):33-9. PubMed ID: 1083317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitogenic responsiveness and monocyte-lymphocyte interaction of early and late rosette-forming cell populations of human peripheral blood lymphocytes.
    Taniguchi N; Miyawaki T; Moriya N; Nagaoki T; Kato E
    J Immunol; 1977 Jan; 118(1):193-7. PubMed ID: 299756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlations among cutaneous reactivity to DNCB, PHA-induced lymphocyte blastogenesis and peripheral blood E rosettes.
    Catalona WJ; Tarpley JL; Potvin C; Chretien PB
    Clin Exp Immunol; 1975 Feb; 19(2):327-33. PubMed ID: 1082390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the normal lymphocyte population cytolytic to Burkitt's lymphoma cells of the EB2 cell line.
    Matthews N; Maclaurin BP; Clarke GN
    Aust J Exp Biol Med Sci; 1976 Oct; 53(5):389-98. PubMed ID: 1084744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active E rosette-forming cells in the peripheral blood of patients with chronic active hepatitis.
    de Moura MC; Ramalho F
    Dig Dis Sci; 1979 Jul; 24(7):514-20. PubMed ID: 456238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active T-rosette-forming cells in the peripheral blood of cancer patients.
    Kerman RH; Smith R; Stefani SS; Ezdinili EZ
    Cancer Res; 1976 Sep; 36(9 pt.1):3274-8. PubMed ID: 1086131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections, and other diseases.
    Wybran J; Fudenberg HH
    J Clin Invest; 1973 May; 52(5):1026-32. PubMed ID: 4540711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptors for IgA on human lymphocytes. II. Organ distribution and relationships with other Fc receptor-bearing populations.
    Lydyard PM; Fanger MW
    Scand J Immunol; 1981 Nov; 14(5):509-14. PubMed ID: 6977825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of splenectomy on cellular immunologic parameters in Hodgkin's disease.
    Wagener DJ; Geestman E; Borgonjen A; Haanen C
    Cancer; 1976 May; 37(5):2212-9. PubMed ID: 130968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T and B lymphocytes in myasthenia gravis.
    Itoyama Y; Kawanami S; Goto I; Kuroiwa Y
    Clin Exp Immunol; 1979 Sep; 37(3):452-6. PubMed ID: 315844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depletion of circulating T lymphocytes in pregnancy.
    Bulmer R; Hancock KW
    Clin Exp Immunol; 1977 May; 28(2):302-5. PubMed ID: 301450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of total and stable E-rosettes by lymphocytes from patients with pulmonary tuberculosis stimulated by Con A or PPD.
    Aristizábal L; García LF
    J Clin Lab Immunol; 1985 Jan; 16(1):31-6. PubMed ID: 3981616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppression in Burkitt's lymphoma. I. Cutaneous reactivity to recall antigens: alterations induced by a tumour burden and by BCG administration.
    Magrath IT
    Int J Cancer; 1974 Jun; 13(6):839-49. PubMed ID: 4604572
    [No Abstract]   [Full Text] [Related]  

  • 19. The inhibition of complement-dependent lymphocyte rosette formation by the sera of children with steroid-sensitive hephrotic syndrome and other renal diseases.
    Smith MD; Barratt TM; Hayward AR; Soothill JF
    Clin Exp Immunol; 1975 Aug; 21(2):236-43. PubMed ID: 1183072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunocompetence, immunosuppression, and human breast cancer. III. Prognostic significance of initial level of immunocompetence in early and advanced disease.
    Adler A; Stein JA; Ben-Efraim S
    Cancer; 1980 Apr; 45(8):2074-83. PubMed ID: 7370953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.